Dr. Kirti Singh received her Ph.D. in Molecular and Cellular Pharmacology from the Mercer University, Atlanta in 2023. She is currently a Postdoctoral Scientist at Eli Lilly & Company. Dr. Singh has published her work in various high-impact factor journals. Her research topics mainly include: GPCRs, fibrosis, and asthma.